A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy, Safety and Immunogenicity of Neovacs' TNFalpha-Kinoid in Adult Subjects With Crohn's Disease.

Trial Profile

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy, Safety and Immunogenicity of Neovacs' TNFalpha-Kinoid in Adult Subjects With Crohn's Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Nov 2016

At a glance

  • Drugs Tumour necrosis factor-alpha kinoid (Primary)
  • Indications Crohn's disease
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Neovacs
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 17 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 01 Aug 2013 Planned end date changed from 1 Jun 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top